Bornhäuser M - Search Results

1

Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT.

Martino R, de Wreede L, Fiocco M, van Biezen A, von dem Borne PA, Hamladji RM, Volin L, Bornhäuser M, Robin M, Rocha V, de Witte T, Kröger N, Mohty M; Acute Leukemia Working Party the subcommittee for Myelodysplastic Syndromes of the Chronic Malignancies Working Party of the European group for Blood Marrow Transplantation Group (EBMT). Martino R, et al. Among authors: bornhauser m. Bone Marrow Transplant. 2013 Jun;48(6):761-70. doi: 10.1038/bmt.2012.236. Epub 2012 Dec 3. Bone Marrow Transplant. 2013. PMID: 23208314 Clinical Trial.

2

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin.

Bornhäuser M, Thiede C, Schuler U, Platzbecker U, Freiberg-Richter J, Helwig A, Plettig R, Röllig C, Naumann R, Kroschinsky F, Neubauer A, Ehninger G. Bornhäuser M, et al. Bone Marrow Transplant. 2000 Jul;26(2):119-25. doi: 10.1038/sj.bmt.1702500. Bone Marrow Transplant. 2000. PMID: 10918420

3

Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation.

Ringdén O, Remberger M, Runde V, Bornhäuser M, Blau IW, Basara N, Hölig K, Beelen DW, Hägglund H, Basu O, Ehninger G, Fauser AA. Ringdén O, et al. Among authors: bornhauser m. Bone Marrow Transplant. 2000 May;25 Suppl 2:S6-8. doi: 10.1038/sj.bmt.1702343. Bone Marrow Transplant. 2000. PMID: 10933177 Clinical Trial.

4

Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia.

Platzbecker U, Thiede C, Freiberg-Richter J, Röllig C, Helwig A, Schäkel U, Mohr B, Schaich M, Ehninger G, Bornhäuser M. Platzbecker U, et al. Among authors: bornhauser m. Bone Marrow Transplant. 2001 Mar;27(5):543-6. doi: 10.1038/sj.bmt.1702819. Bone Marrow Transplant. 2001. PMID: 11313690

5

Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis.

Bornhäuser M, Kiehl M, Siegert W, Schetelig J, Hertenstein B, Martin H, Schwerdtfeger R, Sayer HG, Runde V, Kröger N, Theuser C, Ehninger G; Cooperative German Transplant Study Group. Bornhäuser M, et al. Br J Haematol. 2001 Oct;115(1):119-24. doi: 10.1046/j.1365-2141.2001.03074.x. Br J Haematol. 2001. PMID: 11722421 Free article.

6

Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.

Schetelig J, Kröger N, Held TK, Thiede C, Krusch A, Zabelina T, Dubiel M, Rick O, Bornhäuser M, Ehninger G, Zander AR, Siegert W. Schetelig J, et al. Among authors: bornhauser m. Haematologica. 2002 Mar;87(3):299-305. Haematologica. 2002. PMID: 11869943

7

Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.

Hänel M, Kröger N, Sonnenberg S, Bornhäuser M, Krüger W, Kroschinsky F, Hänel A, Metzner B, Birkmann J, Schmid B, Hoffknecht MM, Fiedler F, Ehninger G, Zander AR. Hänel M, et al. Among authors: bornhauser m. Ann Hematol. 2002 Feb;81(2):96-102. doi: 10.1007/s00277-001-0413-8. Epub 2002 Jan 10. Ann Hematol. 2002. PMID: 11907790

8

Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.

Schetelig J, Thiede C, Bornhäuser M, Schwerdtfeger R, Kiehl M, Beyer J, Kröger N, Hensel M, Scheffold C, Ho AD, Kienast J, Neubauer A, Zander AR, Fauser AA, Ehninger G, Siegert W. Schetelig J, et al. Among authors: bornhauser m. Ann Hematol. 2002;81 Suppl 2:S47-8. Ann Hematol. 2002. PMID: 12611075

9

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.

Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR; German Cooperative Transplant Study Group. Kröger N, et al. Among authors: bornhauser m. Ann Hematol. 2003 Jun;82(6):336-42. doi: 10.1007/s00277-003-0654-9. Epub 2003 May 1. Ann Hematol. 2003. PMID: 12728337 Clinical Trial.

10

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.

Sayer HG, Kröger M, Beyer J, Kiehl M, Klein SA, Schaefer-Eckart K, Schwerdtfeger R, Siegert W, Runde V, Theuser C, Martin H, Schetelig J, Beelen DW, Fauser A, Kienast J, Höffken K, Ehninger G, Bornhäuser M; Cooperative German Transplant Study Group. Sayer HG, et al. Among authors: bornhauser m. Bone Marrow Transplant. 2003 Jun;31(12):1089-95. doi: 10.1038/sj.bmt.1704062. Bone Marrow Transplant. 2003. PMID: 12796788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

665 results

Search Page

Filters